GSK669, a NOD2 receptor antagonist, inhibits thrombosis and oxidative stress via targeting platelet GPVI
Guanxing Pan, Lin Chang, Jianjun Zhang, Yangyang Liu, Liang Hu, Si Zhang, Jian Zhang, Jianlin Qiao, Žiga Jakopin, Hu Hu, Jianzeng Dong, Zhongren Ding
Topics & Concepts
GPVIOxidative stressPlateletAntagonistPlatelet activationThrombosisChemistryReceptor antagonistPharmacologyReceptorInternal medicineMedicineBiochemistryPlatelet Disorders and TreatmentsImmune Response and InflammationBlood Coagulation and Thrombosis Mechanisms